George F. Tidmarsh

2017

In 2017, George F. Tidmarsh earned a total compensation of $6.5M as President, Chief Executive Officer and Secretary at La Jolla Pharmaceutical, a 39% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$428,000
Option Awards$5,433,528
Salary$571,000
Other$18,115
Total$6,450,643

Tidmarsh received $5.4M in option awards, accounting for 84% of the total pay in 2017.

Tidmarsh also received $428K in non-equity incentive plan, $571K in salary and $18.1K in other compensation.

Rankings

In 2017, George F. Tidmarsh's compensation ranked 1,338th out of 14,666 executives tracked by ExecPay. In other words, Tidmarsh earned more than 90.9% of executives.

ClassificationRankingPercentile
All
1,338
out of 14,666
91st
Division
Manufacturing
449
out of 5,745
92nd
Major group
Chemicals And Allied Products
115
out of 2,048
94th
Industry group
Drugs
80
out of 1,704
95th
Industry
Biological Products, Except Diagnostic Substances
15
out of 306
95th
Source: SEC filing on August 22, 2018.

Tidmarsh's colleagues

We found four more compensation records of executives who worked with George F. Tidmarsh at La Jolla Pharmaceutical in 2017.

2017

Lakhmir Chawla

La Jolla Pharmaceutical

Chief Medical Officer

2017

Jennifer Carver

La Jolla Pharmaceutical

Chief Operating Officer

2017

Dennis Mulroy

La Jolla Pharmaceutical

Chief Financial Officer

2017

James Rolke

La Jolla Pharmaceutical

Chief Scientific Officer

News

In-depth

You may also like